Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study is designed to evaluate the potential impact of N-acetyl cysteine (NAC) and
coenzyme Q10
(
CoQ10
) each alone or in combination against carbon tetrachloride (CCl
4
)-induced cardiac damage in rats. Animals were treated with CCl
4
in single intraperitoneal dose of 1 mL/Kg body weight; CCl
4
-intoxicated animals were pretreated with 20 mg/kg/d NAC or pretreated with 200 mg/kg/d
CoQ10
or NAC and
CoQ10
with the same previously mentioned doses. Carbon tetrachloride-intoxicated rats showed a significant elevation in nitric oxide and lipid peroxides and downregulation in reduced glutathione level and calcium
adenosine triphosphatase
. Cardiac glycolytic enzymes levels such as lactate dehydrogenase, phosphofructokinase, and hexokinase were declined coupled with a reduction in glucose content after CCl
4
treatment. Moreover, myocardial hydroxyproline level was significantly increased after CCl
4
-treatment indicating accumulation of interstitial collagen. N-acetyl cysteine and/or
CoQ10
effectively alleviated the disturbances in myocardial oxidative stress and antioxidant markers. These antioxidants effectively upregulated the reduction in cardiac energetic biomarkers due to CCl
4
treatment. N-acetyl cysteine and/or
CoQ10
significantly decreased hydroxyproline level compared to that of CCl
4
-treated rats. The current data showed that the aforementioned antioxidants have a remarkable cardioprotective effect, suggesting that they may be useful as prophylactic agents against the detrimental effects of cardiotoxins.
...
PMID:Role of N-Acetylcysteine and Coenzyme Q10 in the Amelioration of Myocardial Energy Expenditure and Oxidative Stress, Induced by Carbon Tetrachloride Intoxication in Rats. 3011 67